Wenyu Wu Department of Nuclear Medicine, Nanjing First Hospital Nanjing Medical University Biography Publications Institution JoVE Articles Wenyu Wu has not added a biography. If you are Wenyu Wu and would like to personalize this page please email our Author Liaison for assistance. Publications Development and Validation of Ga-PSMA-11 PET/CT-based Radiomics Model to Detect Primary Prostate Cancer EJNMMI Research. Sep, 2022 | Pubmed ID: 36175753 Indoleamine 2,3-Dioxygenase Immune Status As a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer Frontiers in Oncology. 2022 | Pubmed ID: 35924153 Antitumour Effects of Apatinib in Progressive, Metastatic Differentiated Thyroid Cancer (DTC) Endocrine. Oct, 2022 | Pubmed ID: 35767182 Whole-body PET Tracking of a D-dodecapeptide and Its Radiotheranostic Potential for PD-L1 Overexpressing Tumors Acta Pharmaceutica Sinica. B. Mar, 2022 | Pubmed ID: 35530129 Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians Frontiers in Oncology. 2022 | Pubmed ID: 35402274 Ga-DOTA-NT-20.3 Neurotensin Receptor 1 PET Imaging As a Surrogate for Neuroendocrine Differentiation of Prostate Cancer Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Sep, 2022 | Pubmed ID: 35177423 LDLR Dysfunction Induces LDL Accumulation and Promotes Pulmonary Fibrosis Clinical and Translational Medicine. Jan, 2022 | Pubmed ID: 35083881 An Efficient Strategy for Digging Protein-protein Interactions for Rational Drug Design - A Case Study with HIF-1α/VHL European Journal of Medicinal Chemistry. Jan, 2022 | Pubmed ID: 34638033 Smart I-Labeled Self-Illuminating Photosensitizers for Deep Tumor Therapy Angewandte Chemie (International Ed. in English). Sep, 2021 | Pubmed ID: 34374188 Use of Chromogranin A for Monitoring Patients With Pancreatic Neuroendocrine Neoplasms Pancreas. Jul, 2021 | Pubmed ID: 34347728 Safety and Tolerability of Ga-NT-20.3, a Radiopharmaceutical for Targeting Neurotensin Receptors, in Patients with Pancreatic Ductal Adenocarcinoma: the First In-human Use European Journal of Nuclear Medicine and Molecular Imaging. Apr, 2021 | Pubmed ID: 33006657 Total Synthesis, Chemical Modification and Structure-activity Relationship of Bufadienolides European Journal of Medicinal Chemistry. Mar, 2020 | Pubmed ID: 31945667 Design, Synthesis and Evaluation of 2-amino-imidazol-4-one Derivatives As Potent β-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) Inhibitors Bioorganic & Medicinal Chemistry Letters. Dec, 2019 | Pubmed ID: 31711785 [Ga]Ga-NOTA-MAL-Cys-exendin-4, a Potential GLP-1R Targeted PET Tracer for the Detection of Insulinoma Nuclear Medicine and Biology. 2019 | Pubmed ID: 31450071 A Novel and Efficient Synthesis of Phenanthrene Derivatives Via Palladium/norbornadiene-catalyzed Domino One-pot Reaction Beilstein Journal of Organic Chemistry. 2019 | Pubmed ID: 30800179 Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative Molecules (Basel, Switzerland). Jun, 2017 | Pubmed ID: 28635646 Development and Structural Modification of BACE1 Inhibitors Molecules (Basel, Switzerland). Dec, 2016 | Pubmed ID: 28025519 An Efficient Chemical Synthesis of Scutellarein: An in Vivo Metabolite of Scutellarin Molecules (Basel, Switzerland). Feb, 2016 | Pubmed ID: 26927039 A New and Efficient Synthesis of 6-O-methylscutellarein, the Major Metabolite of the Natural Medicine Scutellarin Molecules (Basel, Switzerland). Jun, 2015 | Pubmed ID: 26042857 Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression Lulu Zhang*1, Siqi Zhang*2, Wenyu Wu1, Xingkai Wang2, Jieting Shen2, Dongyuan Wang4, Kuan Hu*2,3, Ming-Rong Zhang*3, Feng Wang*1, Rui Wang*2 1Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 3Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology JoVE 65047 Cancer Research
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression Lulu Zhang*1, Siqi Zhang*2, Wenyu Wu1, Xingkai Wang2, Jieting Shen2, Dongyuan Wang4, Kuan Hu*2,3, Ming-Rong Zhang*3, Feng Wang*1, Rui Wang*2 1Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 2State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 3Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology JoVE 65047 Cancer Research
